Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Colorectal cancer cells expressing Mex3a drive recurrence after chemotherapy

    Nature Cancer volume 3, pages 1024–1025 (2022)Cite this article

    Subjects

    Many patients with colorectal cancer (CRC) relapse after chemotherapy. Tumor cells that do not completely adapt to their environment (owing to an incomplete set of CRC driver mutations) enter a latent state, in which the expression of Mex3a is upregulated. Mex3a+ cells are chemoresistant and reactivate after treatment, which leads to regeneration of the disease.

    This is a preview of subscription content, access via your institution

    Access options

    Buy article

    Get time limited or full article access on ReadCube.

    $32.00

    Buy

    All prices are NET prices.

    Fig. 1: Lineage-tracing analysis of Mex3a+ cells in CRC mouse organoids during chemotherapy.

    References

    1. Lo, Y.-H., Karlsson, K. & Kuo, C. J. Applications of organoids for cancer biology and precision medicine. Nat. Cancer 1, 761–773 (2020). A Review article that discusses the potential of organoids for personalized medicine.

      Article  Google Scholar 

    2. Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124–1134 (2017). This Review discusses the role of tumor environment niche factors in cancer stem cell plasticity.

      Article  CAS  Google Scholar 

    3. Nusse, Y. M. et al. Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature 559, 109–113 (2018). This Article reveals the acquisition of a fetal-like program by the damaged intestinal mucosa.

      Article  CAS  Google Scholar 

    4. Boumahdi, S. & de Sauvage, F. J. The great escape: tumour cell plasticity in resistance to targeted therapy. Nat. Rev. Drug Discov. 19, 39–56 (2020). A Review article discussing the importance of cellular plasticity and the microenvironment in therapy resistance.

      Article  CAS  Google Scholar 

    5. Shen, S., Vagner, S. & Robert, C. Persistent Cancer. Cells: The Deadly Survivors. Cell 183, 860–874 (2020). This Article reviews the mechanisms utilized by tumor cells to survive drug treatments.

      Article  CAS  Google Scholar 

    Download references

    Additional information

    Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    This is a summary of: Batlle, E. et al. Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy. Nat. Cancer https://doi.org/10.1038/s43018-022-00402-0 (2022).

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Colorectal cancer cells expressing Mex3a drive recurrence after chemotherapy. Nat Cancer 3, 1024–1025 (2022). https://doi.org/10.1038/s43018-022-00409-7

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1038/s43018-022-00409-7

    Search

    Advanced search

    Quick links

    Nature Briefing: Cancer

    Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

    Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer